Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2008
09/18/2008WO2008111568A1 Modified metal complexes and use thereof
09/18/2008WO2008111567A1 Metal complex
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008111077A2 Self-assembled polyhedral multimeric chemical structures
09/18/2008WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008111009A1 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008110699A2 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
09/18/2008WO2008110691A1 Novel tricyclic derivatives, method for preparing same and pharmaceutical compositions containing same
09/18/2008WO2008110598A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008WO2008110523A1 Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
09/18/2008WO2008110508A1 Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity
09/18/2008WO2008074803A3 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
09/18/2008WO2008060487B1 Polymorphs of nicotinic intermediates
09/18/2008WO2008031566A3 Novel pyridopyrazine n-oxides
09/18/2008WO2007003386A9 Imidazopyridine derivatives as acid pump antagonists
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227979 Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these
09/18/2008US20080227839 Kinase Inhibitors
09/18/2008US20080227807 6-(Carbocyclylmethyl- or heterocyclylmethyl-substituted)pyrrolo[2,3-c]pyridine derivatives; use alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or mediated conditions or diseases
09/18/2008US20080227806 prodrug is a dihydrotrigoneline CDS moiety coupled to an epoxysuccinyl peptide cysteine protease inhibitor moiety; Alzheimer's disease and vascular dementia
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080227777 Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1
09/18/2008US20080227773 N-[4-(1,4-Diaza-bicyclo[3.2.2]non-4-yl)-phenyl]-benzamide; disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse
09/18/2008US20080227772 Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands
09/18/2008US20080226591 Compounds for the Treatment of Hepatitis C
09/18/2008US20080226590 Compounds for the Treatment of Hepatitis C
09/18/2008US20080224603 Naphthalene compound and organic light-emitting device using the compound
09/18/2008US20080223444 perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes
09/18/2008DE102007009235A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
09/18/2008CA2680625A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
09/18/2008CA2680244A1 Modified metal complex and use thereof
09/18/2008CA2680240A1 Metal complex
09/18/2008CA2680029A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008CA2679884A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008CA2679754A1 Substituted heterocycle fused gamma-carbolines synthesis
09/18/2008CA2679701A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008CA2679346A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008CA2677713A1 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
09/17/2008EP1970371A1 Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them
09/17/2008EP1969112A1 Cleaning agent comprising complexes with bleach catalytic activity
09/17/2008EP1968978A2 Forms of dolasetron mesylate and processes for their preparation
09/17/2008EP1968977A1 Aryl-isoxazol-4-yl-imidazoý1, 5-a¨pyridine derivatives
09/17/2008EP1968976A1 Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors
09/17/2008EP1968975A2 Tylophorine analogs as antitumor agents
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008EP1968588A2 Crystalline forms of dolasetron base and processes for preparation thereof
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
09/17/2008CN101268077A Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
09/17/2008CN101268076A Diazepinoquinolines, synthesis thereof, and intermediates thereto
09/17/2008CN101268075A Substituted tetrahydro-1H-pyrido[4,3-B]indoles as serotonin receptors agonists and antagonists
09/17/2008CN101268074A 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
09/17/2008CN101268073A Heterocyclic compound, and production process and use thereof
09/17/2008CN101268072A DNA-PK inhibitors
09/17/2008CN101268051A Isotopically substituted proton pump inhibitors
09/17/2008CN101268048A Carbazole derivatives
09/17/2008CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands
09/17/2008CN101265259A Novel IDO inhibitor and its usage method
09/17/2008CN101265254A Novel IDO inhibitor and its usage method
09/17/2008CN100418968C Pirazino(aza)indole derivatives
09/17/2008CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases
09/17/2008CN100418966C 8-iodo-imidazo[1,2-alpha] pyridine-3-acetamide compound and preparing method
09/17/2008CN100418965C Imidazopyridine derivatives
09/17/2008CN100418948C Hydroxypyridine cgrp receptor antagonists
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/16/2008US7425562 Inhibitors of cruzipain and other cysteine proteases
09/16/2008US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/16/2008US7425557 Inhibitors of glycogen synthase kinase 3
09/16/2008US7425550 Lactam glycogen phosphorylase inhibitors and method of use
09/16/2008US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/12/2008WO2008109613A1 Benzo[c][2,7]naphthyridine derivatives, and their use as kinase inhibitors
09/12/2008WO2008109599A1 Pyrimido [5,4-c] quinoline-2, 4-diamine derivatives and methods of use thereof
09/12/2008WO2008109584A1 Hcv ns5b inhibitors
09/12/2008WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008108730A1 Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
09/12/2008WO2008107399A1 Substituted oxindole compounds
09/12/2008WO2008107125A1 New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/12/2008WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/12/2008WO2008070016A3 Inhibitors of akt activity
09/12/2008WO2008063609A3 Diimide-based semiconductor materials and methods of preparing and using the same
09/12/2008WO2004078116A9 P38 inhibitors and methods of use thereof
09/12/2008CA2682756A1 New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/12/2008CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2679735A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/11/2008US20080221329 Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
09/11/2008US20080221196 Pharmaceutically active isoindoline derivatives
09/11/2008US20080221154 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
09/11/2008US20080221153 N3-substituted imidazopyridine c-kit inhibitors
09/11/2008US20080221152 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
09/11/2008US20080221151 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 646